BiTE
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
BiTE
Aug 10, 2024, 03:56 |
Insight
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia
Bichoy Gabra, Oncology Infusion Pharmacy Services Manager at Moffitt Cancer Center, shared on X: "Many…
Jul 11, 2024, 10:12 |
Blog
Shilpa Gupta: Stellar talk by Neeraj Agarwal on tremendous progress in mCRpC in Athens
Shilpa Gupta shared a post on X: “Stellar talk by Neeraj Agarwal on tremendous progress…
May 18, 2024, 02:46 |
Drugs
Vivek Subbiah: US FDA granted accelerated approval to tarlatamab-dlle
Vivek Subbiah shared on X: "New FDA Approval. Today the US FDA granted accelerated approval…
Dec 26, 2023, 12:53 |
Insight
Aaron Goodman: All the FDA BiTEs and what you need to know!
Aaron Goodman shared on X: "All the FDA BiTEs and what you need to know!…
Nov 6, 2023, 17:36 |
Blog
Manni Mohyuddin: Every day in my clinic, there is selection bias in favor of an increase in PFS for CAR T-cell therapy
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
All:
5
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube